Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease

BACKGROUND: Peripheral arterial disease (PAD) of lower extremities comprises a clinical spectrum that extends from asymptomatic patients to critical limb ischemia (CLI) patients. 10% to 40% of the patients are at the risk of primary amputation. This study was planned in “no-option” patients of CLI d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Pawan Kumar, Shivashankar, P., Rajkumar, M., Mahapatra, Subhendu S., Desai, Sanjay C., Dhar, Anita, Krishna, Vinay, Raviraja, N. S., Bhat, Samatha, Viswanathan, Pachaiyappan, Kannan, Suresh, Abraham, Jijy, Boggarapu, Hema, Manjuprasad, M. S., Udaykumar, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068167/
https://www.ncbi.nlm.nih.gov/pubmed/37005673
http://dx.doi.org/10.1186/s13287-023-03292-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068167/
https://www.ncbi.nlm.nih.gov/pubmed/37005673
http://dx.doi.org/10.1186/s13287-023-03292-w

Ejemplares similares